Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proactive Therapeutic Drug Monitoring Versus Routine Care With the Novel Biologics in Psoriasis : a Pragmatic, Multicentric, Randomised, Controlled Study

NCT06398106 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT06398106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06398106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proactive Therapeutic Drug Monitoring Versus Routine Care With the Novel Biologics in Psoriasis : a Pragmatic, Multicentric, Randomised, Controlled Study
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Recruiting
Start date
December 20, 2024
Completion date
March 1, 2028
Enrollment
210 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris